Related Articles
Current state and challenges of emerging biomarkers for immunotherapy in hepatocellular carcinoma (Review)
Ferroptosis, pyroptosis and necroptosis in hepatocellular carcinoma immunotherapy: Mechanisms and immunologic landscape (Review)
Anti‑PD‑1/PD‑L1 and anti‑CTLA‑4 associated checkpoint inhibitor pneumonitis in non‑small cell lung cancer: Occurrence, pathogenesis and risk factors (Review)
The immune landscape of hepatocellular carcinoma‑where we are? (Review)
Immunotherapy in malignant peritoneal mesothelioma (Review)